British Drug Maker AstraZeneca Plc | The Business Standard

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca

Coronavirus chronicle

AstraZeneca vaccine 79% effective in US trial

Many European countries have resumed using the shot in their inoculation programmes after a regional regulator said it was safe

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo

Coronavirus chronicle

UK to receive 10 million AstraZeneca Covid-19 vaccine doses from India's Serum Institute

Global Economy

AstraZeneca has sold its stake in Moderna for more than $1 billion: The Times

Coronavirus chronicle

AstraZeneca to miss second-quarter EU vaccine supply target by half

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier

Coronavirus chronicle

AstraZeneca vaccine could get WHO emergency approval by mid-February

File Photo: A member of the medical staff holds a vial of the Oxford-AstraZeneca COVID-19 vaccine at the Foch hospital in Suresnes, near Paris, France, February 8, 2021. REUTERS/Benoit Tessier

Coronavirus chronicle

Global health officials back AstraZeneca vaccine after South Africa study rings alarm

A vail of the Oxford-AstraZeneca Covid-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021. REUTERS/Peter Cziborra/File Photo

Coronavirus chronicle

UK says Astrazeneca vaccine prevents Covid-19 death as South Africa halts shots

Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters

Coronavirus chronicle

Oxford/AstraZeneca Covid shot less effective against South African variant: Study

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas

Coronavirus chronicle

AstraZeneca to increase EU vaccine deliveries by 30 percent

An employee in personal protective equipment (PPE) removes vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine from a visual inspection machine inside a lab at Serum Institute of India Photo: Reuters/Francis Mascarenhas

Coronavirus chronicle

Germany threatens legal action over vaccine delays

A health department employee counts vials of the vaccine developed by Oxford/AstraZeneca as she prepares to pack them up before they are transported from the state storage to a regional one, during the coronavirus disease (Covid-19) pandemic, in Bhubaneswar, India, January 13, 2021. REUTERS/Danish Siddiqui

Coronavirus chronicle

Mexico to import AstraZeneca vaccine from India, president says

Coronavirus chronicle

AstraZeneca contract includes UK as 'best effort' base for output to EU

Oxford-AstraZeneca's Covid-19 vaccine. Photo: Reuters.

Coronavirus chronicle

EU demands AstraZeneca plan to break vaccine deadlock